LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Secured Loans History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Secured Loans | ₹9.72 Cr | ₹7.18 Cr | ₹0.39 Cr | ₹0.86 Cr | ₹151 Cr |
What is the latest Secured Loans ratio of LYKA LABS ?
| Year | Secured Loans |
|---|---|
| Mar2025 | ₹9.72 Cr |
| Mar2024 | ₹7.18 Cr |
| Mar2023 | ₹0.39 Cr |
| Mar2022 | ₹0.86 Cr |
| Mar2021 | ₹151 Cr |
How is Secured Loans of LYKA LABS Trending?
| Years | Secured Loans | % Change | |
|---|---|---|---|
| Mar2025 | ₹9.72 Cr | 35.48 | |
| Mar2024 | ₹7.18 Cr | 1,759.07 | |
| Mar2023 | ₹0.39 Cr | -55.06 | |
| Mar2022 | ₹0.86 Cr | -99.43 | |
| Mar2021 | ₹151 Cr | - | |
Compare Secured Loans of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹250.1 Cr | -4% | -2.5% | -37.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,815.0 Cr | 0.5% | 6.2% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,678.0 Cr | 4.7% | 9% | 7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,323.0 Cr | -3.7% | 7.2% | 49.8% | Stock Analytics | |
| CIPLA | ₹114,585.0 Cr | -0.6% | 5% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,067.0 Cr | -1.9% | -4.6% | -2.8% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -4% |
-2.5% |
-37.3% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses